Delek US Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Delek US Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.28B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $2.33B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $2.48B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $2.20B | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $2.47B | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $2.77B | Feb 28, 2020 |
| FY2019 | Jun 30, 2018 | $2.64B | Feb 28, 2020 |
| FY2019 | Mar 31, 2018 | $2.35B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.48B | Jun 27, 2019 |
| FY2018 | Sep 30, 2017 | $2.37B | Jun 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.43B | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $2.89B | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $2.76B | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $2.64B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $3.04B | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $3.31B | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $3.13B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.94B | Feb 26, 2025 |
| FY2024 | Sep 30, 2023 | $4.63B | Feb 26, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.48B | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $2.37B | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $1.23B | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $1.18B | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $1.08B | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $1.08B | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $1.15B | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $886.10M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $4.78B | Mar 1, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.30M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $178.00M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | ($106.40M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | ($172.70M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($413.80M) | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | ($76.80M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | ($37.20M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | ($32.60M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($164.90M) | Feb 26, 2025 |
| FY2024 | Sep 30, 2023 | $128.70M | Feb 26, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $164.60M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $295.70M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | ($33.50M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | ($125.80M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($403.40M) | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | ($121.90M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $4.60M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $29.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($143.90M) | Feb 26, 2025 |
| FY2024 | Sep 30, 2023 | $212.10M | Feb 26, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $269.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $252.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $272.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $313.70M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $200.40M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $234.60M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $274.70M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $247.60M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $175.90M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $106.10M | Jun 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $535.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($66.80M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.01B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $425.30M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $371.40M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($282.90M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $575.20M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $560.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $319.70M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $248.00M | Jun 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $529.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $427.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $392.50M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $280.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $222.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $269.40M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $413.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $322.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $172.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $46.30M | Jun 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.85B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.67B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.17B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $8.19B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $6.81B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $6.13B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $7.02B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $5.76B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.94B | Jun 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.98B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.96B | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $1.18B | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $1.35B | Mar 1, 2018 |
| FY2017 | Dec 31, 2014 | $1.20B | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $475.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $475.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $687.50M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $702.30M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $729.70M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $729.70M | Mar 1, 2023 |
| FY2022 | Dec 31, 2019 | $855.70M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $857.80M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $816.60M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $12.20M | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($311.10M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($205.70M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $430.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $507.90M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $384.70M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $522.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.21B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $981.80M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $767.80M | Jun 27, 2019 |
| FY2017 | Dec 31, 2016 | $522.30M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $625.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $735.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $821.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $841.30M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $856.50M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $787.50M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $955.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.08B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $931.80M | Jun 27, 2019 |
| FY2018 | Dec 31, 2016 | $689.20M | Jun 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.23B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.77B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.60B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.05B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.22B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.35B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.07B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.78B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.47B | Jun 27, 2019 |
| FY2017 | Dec 31, 2016 | $832.90M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | (1) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 5 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | (1) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 5 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 81.53M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | 67.15M | Mar 1, 2018 |